Welcome : Guest

Actelion Pharmaceuticals Ltd. (Switzerland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Actelion Pharmaceuticals Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 18 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-01935
Price: $900
Company Type: Public
Pages: 21
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Actelion Pharmaceuticals Ltd.’s (Operations) Sales by Product Segment Worldwide (2015) in Percentage for Opsumit, Tracleer, Veletri, Ventavis, Valchlor, Zavesca, and Others......3
Table 2: Actelion Pharmaceuticals Ltd.’s (Operations) Sales by Geographic Region Worldwide (2015) in Percentage for United States, Europe, Japan, and Rest of the World......4
Biopharmaceuticals......5
Table 3: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......5
Pulmonary Arterial Hypertension (PAH)......6
Table 4: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......6
Table 5: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......7
Table 6: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......8
Table 7: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......9
Table 8: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......10
Table 9: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......11
Table 10: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......12
Table 11: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......13
Table 12: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......14
Table 13: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......15
Biopharmaceuticals......16
Table 14: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......16
Table 15: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......17
Table 16: Actelion AG’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Europe, Japan and Rest of the World......18
Table 17: Actelion AG’s Sales by Country Worldwide (2013) in Percentage for Switzerland, United States, Europe and Others......19
Table 18: Actelion AG’s Sales by Product Segment Worldwide (2012-2013) in CHF Million for Tracleer, Opsumit, Veletri, Ventavis, Zavesca and Others......20